Balance Assessment Scale and Strength Measurement Protocol to Measure Functionality in Adults With Spinal Deformity (F-ASD)
Primary Purpose
Spinal Deformity
Status
Active
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Balance Assessment Scale
Trunk strength measurement with EMG
MRI spine/pelvis
EOS stereoradiographic full body exam
Balance Assessment Scale 2
Trunk strength measurement with EMG 2
Sponsored by
About this trial
This is an interventional diagnostic trial for Spinal Deformity
Eligibility Criteria
Inclusion criteria pathological subjects:
- Adult (>18 years old) subjects suffering from a adult spinal deformity with sagittal or coronal plane misalignment diagnosed on EOS imaging.
- Ability to walk at least 50 meters distance independently without a walking aid.
- No documented neurological disease or vestibular lesion affecting balance nor a current history of musculoskeletal disorders of the lower extremities affecting motor performance.
Inclusion criteria control group:
- Adults (> 18 year old)
- No current history of back pain and spinal deformity.
- Ability to walk at least 1000 meters distance independently without a walking aid.
- No documented neurological disease or vestibular lesion affecting balance nor a current history of musculoskeletal disorders of the lower extremities affecting motor performance.
Exclusion criteria ASD patients:
- Age < 18 years old and > 79 years old
- Absence of adult spinal deformity
- Non-ability to walk at least 50 meters distance independently, with or without a walking aid.
- Missing patient informed consent
- Patients presenting with a neurological disease affecting balance other than Parkinson's disease such as stroke and/or Vestibular lesion
- Patients with a history of spinal fusion surgery.
- Patients with a current history of diagnosed musculoskeletal disorders of the trunk and/or lower extremities affecting the motor performance such as severe hip arthrosis with or without flexion contracture, severe knee arthrosis, severe ankle arthrosis, severe leg length discrepancy (> 3 cm)
Exclusion criteria control group:
- Age < 18 years old and > 79 years old
- Backpain and/or Sciatica at time of the study
- Presence of adult spinal deformity leading to a pathological sagittal alignment
- Non-ability to walk at least 1000 meters distance independently without a walking aid
- Missing patient informed consent
- Patients presenting with a neurological disease affecting balance such as Stroke, Parkinson's disease and/or Vestibular lesion
- Patients with a current history of diagnosed musculoskeletal disorders of the trunk and/or lower extremities affecting the motor performance such as severe hip arthrosis with or without flexion contracture, severe knee arthrosis, severe ankle arthrosis, severe leg length discrepancy (> 3 cm)
Sites / Locations
- UZ Leuven
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Control group
ASD group
Arm Description
Healthy subjects or volunteers Intervention: Balance Assesment Scale Trunk strength measurement with EMG MRI spine/pelvis EOS stereoradiographic full body exam
Patient group with ASD Intervention: Balance Assesment Scale Trunk strength measurement with EMG MRI spine/pelvis 2 EOS stereoradiographic full body exam Balance Assesment Scale 2 Trunk strength measurement with EMG 2
Outcomes
Primary Outcome Measures
Balance performance on the newly developed ASD specific balance scale
Balance performance is measured by two raters to assess interrater reliability of the new scale. Patients will also return within two weeks after the first measurement and repeat the balance assessment to assess the test-retest reliability. Data on both ASD patients and Controls will also serve as a first normative and clinical database.
Balance performance on the newly developed ASD specific balance scale
Balance performance is measured by two raters to assess interrater reliability of the new scale. Patients will also return within two weeks after the first measurement and repeat the balance assessment to assess the test-retest reliability. Data on both ASD patients and Controls will also serve as a first normative and clinical database.
Trunk muscle strength
Trunk muscle strength is measured with a hand-held dynamometer and repeated within two weeks after the first measurement to assess test-retest reliability.Data of ASD patients and controls will also serve as a first normative and clinical database.
Trunk muscle strength
Trunk muscle strength is measured with a hand-held dynamometer and repeated within two weeks after the first measurement to assess test-retest reliability.Data of ASD patients and controls will also serve as a first normative and clinical database.
Secondary Outcome Measures
Echointensity of trunk muscles on MRI
Fatty infiltration of trunk muscles is measured by the difference in echointensity on MRI images. This will be related to balance performance and trunk muscle strength.
Static 2D radiographic evaluation of spinopelvic parameters
Spinopelvic parameters are obtained on biplanar radiographic images. These will be related to balance performance and trunk muscle strength.
Full Information
NCT ID
NCT04642456
First Posted
November 16, 2020
Last Updated
September 15, 2023
Sponsor
Universitaire Ziekenhuizen KU Leuven
1. Study Identification
Unique Protocol Identification Number
NCT04642456
Brief Title
Balance Assessment Scale and Strength Measurement Protocol to Measure Functionality in Adults With Spinal Deformity
Acronym
F-ASD
Official Title
Development and Reliability of a Balance Assessment Scale and Trunk Strength Measurement Protocol to Measure Functionality in Adults With Spinal Deformity
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 1, 2021 (Actual)
Primary Completion Date
December 1, 2024 (Anticipated)
Study Completion Date
December 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universitaire Ziekenhuizen KU Leuven
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Develop reliable methods for functional assessment, for both balance and trunk strength, of Adult Spinal Deformity (ASD) patients and create a first clinical and normative database
Compare functionality of ASD and control subjects
Relate functionality of ASD patients to their pathology, in terms of spinal deformity and muscle condition
Detailed Description
The overall aim of the project is to initiate the shift from 2D to 3D mechanically correct and dynamically informed decision-making in Adolescent Idiopathic Scoliosis (AIS), by identifying and integrating the key parameters that overcome the present limitations of 2D static AIS care. Within the timeframe of the project, we will not be able to identify and integrate the key parameters that will overcome all undesired surgical outcomes and therefore, in addition to the overall surgical outcome assessed by patient reported outcome measures (PROMs) we will specifically focus on post-surgery shoulder balance. Since an elevated shoulder after surgery is one of the most common undesired surgical outcomes (approximately 16% of the treated AIS patients) linked with treatment satisfaction and psychological well-being.
To achieve the overall aim, the project comprises two objectives that will allow us to advance towards 3D dynamically informed decision-making in AIS care:
To shift towards a 3D mechanically correct overview of the spinal deformity. The current state-of-the-art guidelines for the selection of fusion levels in AIS patients are based on 2D static radiographic parameters[26]. In order to improve the current state-of-the-art evaluation method, efforts should be made towards a 3D dynamic visualization of the deformity, especially considering that AIS is a 3D deformity of the spine. In addition, the treating surgeon has only limited information on the mechanical behavior of the spine of the AIS patient as the traction radiograph tests that show the displacement of the spine are typically only assessed qualitatively. To overcome this issue, the spine stiffness should be incorporated in order to thrive towards a biomechanically-informed state-of-the-art 3D model.
To identify the key 3D parameters that should be considered by the surgeon Once a biomechanically-informed subject specific 3D model that incorporates the mechanical behavior of the spine is developed within objective 1, the crucial next step will be to identify the key parameters that have the potential to improve the clinical decision-making in AIS. As highlighted before, we will focus on post-surgery shoulder balance and the PROMs.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Deformity
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
control group with healthy subjects and patient group with spinal deformity (ASD)
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control group
Arm Type
Other
Arm Description
Healthy subjects or volunteers
Intervention:
Balance Assesment Scale Trunk strength measurement with EMG MRI spine/pelvis EOS stereoradiographic full body exam
Arm Title
ASD group
Arm Type
Other
Arm Description
Patient group with ASD
Intervention:
Balance Assesment Scale Trunk strength measurement with EMG MRI spine/pelvis 2 EOS stereoradiographic full body exam Balance Assesment Scale 2 Trunk strength measurement with EMG 2
Intervention Type
Diagnostic Test
Intervention Name(s)
Balance Assessment Scale
Intervention Description
The newly developed balance, based on the Balance Evaluation Systems Test (BESTest) and Trunk Control Measurement Scale (TCMS), will be administered by two raters (normative and clinical database + interrater reliability)
Intervention Type
Diagnostic Test
Intervention Name(s)
Trunk strength measurement with EMG
Intervention Description
A trunk strength protocol in sitting position, using a hand-held dynamometer is developed. During the trunk strength measurements muscle activity of certain muscles of the trunk will be measured using surface electromyography (EMG)
Intervention Type
Diagnostic Test
Intervention Name(s)
MRI spine/pelvis
Intervention Description
We will be capturing 3D Magnetic Resonance (MR) images of the subject lying supine with extended knees, using a T1 weighted spine-echo (SE) sequence with interslice distance 3 mm in the area of the hip) extended with full spine MRI images (sagittal full spine T1- and T2- weighted images as part of the standard sagittal view of full spine to check for significant stenosis or spinal cord pathology) and additional T1-weighted axial slices at level L4, T12 and T8 with interslice distance 4 mm.The field of view covers the full spine, pelvis and hip smaller trochanter.
Intervention Type
Diagnostic Test
Intervention Name(s)
EOS stereoradiographic full body exam
Intervention Description
Every subject included in the study will undergo a stereoradiographic full body EOS exam completed with Gravity Line (GL) location, recorded by a force plate on the floor
Intervention Type
Diagnostic Test
Intervention Name(s)
Balance Assessment Scale 2
Intervention Description
Repeating the newly developed balance test (test-retest reliability) within 2 weeks after first measurement
Intervention Type
Diagnostic Test
Intervention Name(s)
Trunk strength measurement with EMG 2
Intervention Description
Repeating the trunk strength protocol with EMG within 2 weeks after the first measurement (test-retest reliability)
Primary Outcome Measure Information:
Title
Balance performance on the newly developed ASD specific balance scale
Description
Balance performance is measured by two raters to assess interrater reliability of the new scale. Patients will also return within two weeks after the first measurement and repeat the balance assessment to assess the test-retest reliability. Data on both ASD patients and Controls will also serve as a first normative and clinical database.
Time Frame
Day 1
Title
Balance performance on the newly developed ASD specific balance scale
Description
Balance performance is measured by two raters to assess interrater reliability of the new scale. Patients will also return within two weeks after the first measurement and repeat the balance assessment to assess the test-retest reliability. Data on both ASD patients and Controls will also serve as a first normative and clinical database.
Time Frame
Day 2
Title
Trunk muscle strength
Description
Trunk muscle strength is measured with a hand-held dynamometer and repeated within two weeks after the first measurement to assess test-retest reliability.Data of ASD patients and controls will also serve as a first normative and clinical database.
Time Frame
Day 1
Title
Trunk muscle strength
Description
Trunk muscle strength is measured with a hand-held dynamometer and repeated within two weeks after the first measurement to assess test-retest reliability.Data of ASD patients and controls will also serve as a first normative and clinical database.
Time Frame
Day 2
Secondary Outcome Measure Information:
Title
Echointensity of trunk muscles on MRI
Description
Fatty infiltration of trunk muscles is measured by the difference in echointensity on MRI images. This will be related to balance performance and trunk muscle strength.
Time Frame
Day 1
Title
Static 2D radiographic evaluation of spinopelvic parameters
Description
Spinopelvic parameters are obtained on biplanar radiographic images. These will be related to balance performance and trunk muscle strength.
Time Frame
Day 1
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria pathological subjects:
Adult (>18 years old) subjects suffering from a adult spinal deformity with sagittal or coronal plane misalignment diagnosed on EOS imaging.
Ability to walk at least 50 meters distance independently without a walking aid.
No documented neurological disease or vestibular lesion affecting balance nor a current history of musculoskeletal disorders of the lower extremities affecting motor performance.
Inclusion criteria control group:
Adults (> 18 year old)
No current history of back pain and spinal deformity.
Ability to walk at least 1000 meters distance independently without a walking aid.
No documented neurological disease or vestibular lesion affecting balance nor a current history of musculoskeletal disorders of the lower extremities affecting motor performance.
Exclusion criteria ASD patients:
Age < 18 years old and > 79 years old
Absence of adult spinal deformity
Non-ability to walk at least 50 meters distance independently, with or without a walking aid.
Missing patient informed consent
Patients presenting with a neurological disease affecting balance other than Parkinson's disease such as stroke and/or Vestibular lesion
Patients with a history of spinal fusion surgery.
Patients with a current history of diagnosed musculoskeletal disorders of the trunk and/or lower extremities affecting the motor performance such as severe hip arthrosis with or without flexion contracture, severe knee arthrosis, severe ankle arthrosis, severe leg length discrepancy (> 3 cm)
Exclusion criteria control group:
Age < 18 years old and > 79 years old
Backpain and/or Sciatica at time of the study
Presence of adult spinal deformity leading to a pathological sagittal alignment
Non-ability to walk at least 1000 meters distance independently without a walking aid
Missing patient informed consent
Patients presenting with a neurological disease affecting balance such as Stroke, Parkinson's disease and/or Vestibular lesion
Patients with a current history of diagnosed musculoskeletal disorders of the trunk and/or lower extremities affecting the motor performance such as severe hip arthrosis with or without flexion contracture, severe knee arthrosis, severe ankle arthrosis, severe leg length discrepancy (> 3 cm)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lieven Moke
Organizational Affiliation
Universitaire Ziekenhuizen KU Leuven
Official's Role
Principal Investigator
Facility Information:
Facility Name
UZ Leuven
City
Leuven
State/Province
Vlaams-Brabant
ZIP/Postal Code
3000
Country
Belgium
12. IPD Sharing Statement
Learn more about this trial
Balance Assessment Scale and Strength Measurement Protocol to Measure Functionality in Adults With Spinal Deformity
We'll reach out to this number within 24 hrs